In a recent follow-up study, tissue microarray analysis further confirmed higher DDAH1 expression in prostate cancer compared to benign prostatic hyperplasia and normal prostate tissues; the expression of which correlates well with the aggressiveness of prostate cancer and suggests its role in disease progression (54). The gene discussed is DDAH1; the disease is prostate carcinoma.